M
Melissa Pyle
Researcher at University of Manchester
Publications - 43
Citations - 1152
Melissa Pyle is an academic researcher from University of Manchester. The author has contributed to research in topics: Randomized controlled trial & Mental health. The author has an hindex of 14, co-authored 41 publications receiving 856 citations. Previous affiliations of Melissa Pyle include National Health Service & Manchester Academic Health Science Centre.
Papers
More filters
Journal ArticleDOI
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
Anthony P. Morrison,Anthony P. Morrison,Douglas Turkington,Douglas Turkington,Melissa Pyle,Melissa Pyle,Helen Spencer,Helen Spencer,Alison Brabban,Alison Brabban,Graham Dunn,Tom Christodoulides,Robert Dudley,Robert Dudley,Nicola Chapman,Nicola Chapman,Pauline Callcott,Tim Grace,Victoria Lumley,Laura Drage,Sarah Tully,Sarah Tully,Kerry Irving,Anna Cummings,Anna Cummings,Rory Byrne,Linda Davies,Paul Hutton,Paul Hutton +28 more
TL;DR: Cognitive therapy significantly reduced psychiatric symptoms and seems to be a safe and acceptable alternative for people with schizophrenia spectrum disorders who have chosen not to take antipsychotic drugs.
Journal ArticleDOI
Public perceptions of stigma towards people with schizophrenia, depression, and anxiety.
TL;DR: Examination of public stigma attitudes towards schizophrenia, depression and anxiety found schizophrenia was significantly associated with the most negative stereotypes, least blamed and viewed as least likely to recover compared to anxiety and depression.
Journal ArticleDOI
Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: a feasibility study.
Anthony P. Morrison,Anthony P. Morrison,Melissa Pyle,Nicola Chapman,Paul French,Sophie Parker,Adrian Wells +6 more
TL;DR: Preliminary evidence is provided that MCT is a feasible treatment for people with psychosis, and an adequately powered randomised controlled trial is warranted.
Journal ArticleDOI
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
Anthony P. Morrison,Melissa Pyle,Andrew Gumley,Matthias Schwannauer,Douglas Turkington,Graeme MacLennan,John Norrie,Jemma Hudson,Samantha Bowe,Paul French,Paul French,Rory Byrne,Suzy Syrett,Robert Dudley,Robert Dudley,Hamish J. McLeod,Helen Griffiths,Thomas R. E. Barnes,Linda Davies,David Kingdon,Suzan Aydinlar,James Courtley,Maggie Douglas-Bailey,Elizabeth Graves,Natasha Holden,Jane Hutton,Paul Hutton,Susan Irving,Clare Jackson,Toyah Lebert,Helen Mander,Laura McCartney,Trevor Munro-Clark,Elizabeth Murphy,Mairi Spanswick,Ann Steele,Liesbeth Tip,Sarah Tully +37 more
TL;DR: The results of this trial do not support a recommendation to routinely offer CBT to all people who meet criteria for clozapine-resistant schizophrenia; however, a pragmatic individual trial might be indicated for some.
Journal ArticleDOI
Cognitive therapy for internalised stigma in people experiencing psychosis: A pilot randomised controlled trial
Anthony P. Morrison,Anthony P. Morrison,Eilish Burke,Eilish Burke,Elizabeth Murphy,Melissa Pyle,Melissa Pyle,Samantha Bowe,Filippo Varese,Graham Dunn,Nicola Chapman,Paul Hutton,Mary Welford,Lisa Wood +13 more
TL;DR: Stigma-focused CT appears feasible and acceptable in people with psychosis who have high levels of internalised stigma, including internalised shame, hopelessness and self-rated recovery.